Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447772
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2007-03-13
Brief Title:
Study to Assess the Efficacy and Safety of Dysport in Cervical Dystonia
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
Multicentre Open Study on the Efficacy and Safety of Botulinum Toxin A 500 Units Dysport in the Treatment of Heterogeneous Forms of Cervical Dystonia
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim is to demonstrate equivalent efficacy and safety in the treatment of the two most frequent forms of cervical dystonia predominantly rotational torticollis and predominantly laterocollis with the standard initial dose of 500 units Dysport The patients will be assigned to one of the two basic types of cervical dystonia either predominantly rotational torticollis or predominantly laterocollis on the basis of clinical examination This will determine which therapy is to be administered using the clearly defined structured injection protocols
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-002086-20 | EUDRACT_NUMBER | None | None |